80020-90-2

Upstream product

• 4418-61-5 5-aminotetrazole 
• 80021-71-2 ethyl 6-(4-aminophenyl)-4-methyl-2-pyridinecarboxylate hydrochloride 
• 80021-38-1 4-methyl-6-(4-nitrophenyl)-2-pyridinecarboxylic acid 
• 80021-68-7 2-cyano-4-methyl-6-(4-nitrophenyl)pyridine 
• 80021-65-4 4-methyl-2-(4-nitrophenyl)pyridine N-oxide 
• 80020-89-9 6-(4-Dimethylamino-phenyl)-4-methyl-pyridine-2-carboxylic acid 
• 86696-41-5 6-(4-Amino-phenyl)-4-methyl-pyridine-2-carboxylic acid 
• 20807-64-1 4-methyl-2-(4-nitrophenyl)pyridine 

Relevant academic research and scientific papers

Antiallergic agents. 2. N-(1H-tetrazol-5-yl)-6-phenyl-2-pyridinecarboxamides

A new series of N-(1H-tetrazol-5-yl)-6-phenyl-2-pyridinecarboxamides was prepared to determine the effects of substituents on the benzene and pyridine rings on antiallergic activity in the rat passive cutaneous anaphylaxis (PCA) assay after oral administr

Pyridinecarboxamide derivatives and process for the preparation thereof

N-(5-Tetrazolyl)-6-phenyl-2-pyridinecarboxamide derivatives of the formula: STR1 wherein R is hydrogen, a halogen, a lower alkyl or a lower alkoxy, and the phenyl ring A is a phenyl having a substituent selected from the group consisting of amino, a mono(lower)alkylamino, a di(lower)alkylamino, or a lower aliphatic acylamino, and a pharmaceutically acceptable salt thereof, and process for the preparation thereof. Said pyridinecarboxamide derivatives have excellent anti-allergic activities even by oral administration and are useful as an anti-allergic medicine.